← VIEMED HEALTHCARE, INC. VMD
Market Price
$9.18
Market Cap
$351.93M
P/E Ratio
N/A
Revenue (FY 2025)
↑20.5% YoY
$270.28M
3-Yr CAGR: 24.9%
Net Income
↑34.6% YoY
$21.77M
Net Margin: 8.1%
Free Cash Flow
↑805.2% YoY
$11.93M
FCF Yield: 3.39%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
15.4%
ROA: 526.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (VMD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | $64.5M | — | $47.8M | $9.7M | — | — | — | $22.4M | $16.3M | — |
| FY 2019 | $80.3M | +24.5% | $56.0M | $8.8M | -9.0% | — | — | $19.1M | $5.7M | -64.9% |
| FY 2020 | $131.3M | +63.6% | $80.1M | $26.4M | +199.7% | — | — | $35.1M | $22.1M | +287.0% |
| FY 2021 | $117.1M | -10.8% | $73.4M | $12.5M | -52.6% | — | — | $22.5M | $2.8M | -87.5% |
| FY 2022 | $138.8M | +18.6% | $84.7M | $9.0M | -28.1% | — | — | $27.7M | $4.8M | +76.3% |
| FY 2023 | $183.0M | +31.8% | $112.8M | $14.4M | +60.1% | — | — | $45.2M | $19.1M | +294.2% |
| FY 2024 | $224.3M | +22.5% | $133.2M | $16.2M | +12.4% | — | — | $39.1M | $1.3M | -93.1% |
| FY 2025 | $270.3M | +20.5% | $155.5M | $21.8M | +34.6% | — | — | $51.9M | $11.9M | +805.2% |
Valuation
Market Price
$9.18
Market Cap
$351.93M
Enterprise Value
$350.81M
P/E Ratio
N/A
P/B Ratio
2.49
FCF Yield
3.39%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
57.52%
Operating Margin
8.05%
Net Margin
8.05%
Return on Equity (ROE)
15.38%
Return on Assets (ROA)
526.79%
Asset Turnover
65.41x
Revenue 3-Yr CAGR
24.87%
Financial Health & Liquidity
Current Ratio
0.17
Cash Ratio
0.56
Debt / Equity
0.087
Debt / Assets
2.996
Cash & Equivalents
$13.50M
Total Debt
$12.38M
Book Value / Share
$3.69
Cash Flow Efficiency
Operating Cash Flow
$51.92M
Capital Expenditures (CapEx)
$39.98M
Free Cash Flow
$11.93M
OCF / Revenue
19.21%
FCF / Revenue
4.41%
FCF 3-Yr CAGR
34.99%
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$3.69
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$4.13M
Total Liabilities
$23.91M
Stockholders' Equity
$141.54M
Current Assets
$4.13M
Current Liabilities
$23.91M